Curanex Pharmaceuticals Inc (CURX)
NASDAQ: CURX · Real-Time Price · USD
7.92
+0.47 (6.31%)
Sep 9, 2025, 4:00 PM - Market closed

Curanex Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Net Income
-0.42-0.36-0.02-0.02
Depreciation & Amortization
0.01-00.02
Asset Writedown & Restructuring Costs
0.070.07--
Change in Inventory
--00.02
Change in Accounts Payable
0.130.01--
Change in Other Net Operating Assets
-0.41-0.270.01-0.02
Operating Cash Flow
-0.61-0.56-00
Short-Term Debt Issued
--0-
Total Debt Issued
0.2-0-
Short-Term Debt Repaid
----0
Total Debt Repaid
----0
Net Debt Issued (Repaid)
0.2-0-0
Issuance of Common Stock
0.580.630.07-
Financing Cash Flow
0.780.630.07-0
Net Cash Flow
0.170.070.070
Levered Free Cash Flow
--0.55--
Unlevered Free Cash Flow
--0.55--
Change in Working Capital
-0.28-0.270.020
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q